Get Premium to unlock powerful stock data
NAS:ARGX (Netherlands)  
argenx SE logo

argenx SE

$ 382.11 +4.98 (+1.32%) 10:08 PM EST
P/E:
At Loss
P/B:
8.40
Market Cap:
$ 20.83B
Enterprise V:
$ 18.29B
Volume:
336.93K
Avg Vol (2M):
354.09K
Also Trade In:
Volume:
336.93K
Market Cap $:
20.83B
PE Ratio:
At Loss
Avg Vol (2-Month):
354.09K
Enterprise Value $:
18.29B
PB Ratio:
8.40
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
argenx SE is a clinical stage biotechnology company. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Its product pipeline includes product candidates such as ARGX-111, ARGX-109, ARGX-115, ARGX-112, and others. The company operates in the Netherlands, Germany, Denmark, Belgium, Switzerland, the United States, and Luxembourg. It derives the majority of its revenues from Switzerland.
Name Current Vs Industry Vs History
Cash-To-Debt 203.81
Equity-to-Asset 0.89
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 42.01
Distress
Grey
Safe
Beneish M-Score 8.34
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 74.66
9-Day RSI 71.01
14-Day RSI 67.6
6-1 Month Momentum % -6.27
12-1 Month Momentum % 0.09

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.44
Quick Ratio 8.08
Cash Ratio 7.76
Days Sales Outstanding 10.3

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.8

Financials (Next Earnings Date:2022-07-29 Est.)

ARGX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ARGX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 497.277
EPS (TTM) ($) 1.98
Beta 0.85
Volatility % 47.64
14-Day RSI 67.6
14-Day ATR ($) 13.480576
20-Day SMA ($) 351.1
12-1 Month Momentum % 0.09
52-Week Range ($) 249.5 - 383.81
Shares Outstanding (Mil) 54.24

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

argenx SE Filings

Document Form Filing Date
No Filing Data

Headlines

See More